Marijuana Business Magazine November December 2018

¬NDUSTRY DEVELOPMENTS DEA Moves Some CBD Medicines off Schedule 1 The U.S. Drug Enforcement Administration has taken some cannabidiol (CBD) off the most restrictive class of controlled substances, a move that allows the sale of the first nonsynthetic, cannabis-derived medicine to win federal approval. It’s a decision that immediately affects CBD produc- ers but also signals the agency’s first admission that the plant has medical value. The agency announced Sept. 27 that drugs includ- ing “finished dosage formulations” of CBD with THC below 0.1% will be considered Schedule 5, as long as the What's HAPPEN¬NG International & National News Developments ( ) medications have been approved by the U.S. Food and Drug Administration. It is the first time the agency has removed any type of cannabis from Schedule 1. The action came three months after the FDA approved Epidiolex, a CBD preparation for rare types of epilepsy that is made from cannabis grown in the United Kingdom. Ontario to Cap Licensed Cannabis Producers Canada’s licensed producers of marijuana will be restricted to opening one retail location each in Ontario if new legislation is approved, a move that would pull MAP LEGEND High level of medical development/implementation Medium level of medical development/implementation Low level of medical development/implementation Other - federally illegal but unique circumstances Recreational Countries included have passed legislation at the federal level and must fulfill at least one of the following criteria: • Cultivation or manufacture of medical cannabis allowed. • Doctors can prescribe medical cannabis. • Import and/or export of medical cannabis allowed. High: Countries at the forefront of the global industry. Frameworks are established, and adoption is well underway. Medium: Implementation has begun but is still limited or restricted; lots of room for the market to develop. Low: Legislation has been passed, but implementation is very limited or nonexistent. Decriminalization is not included. © 2018 Marijuana Business Daily, a division of Anne Holland Ventures; this information is current as of Oct. 14, 2018. 20 • Marijuana Business Magazine • November/December 2018